Literature DB >> 9098023

Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement.

V V Smith1, N Gregson, L Foggensteiner, G Neale, P J Milla.   

Abstract

The clinical course, diagnosis, and treatment of 2 patients with acquired intestinal aganglionosis without other neurological involvement or neoplasia are described. They initially presented with constipation and abdominal pain in late childhood. They were found to have enteric ganglionitis with a loss of neurons together with vacuolated nerve cells surrounded by CD3- and CD4-positive T lymphocytes. This process initially affected only the colon but later the entire gastrointestinal tract was involved in 1 patient. Associated with this process there were circulating immunoglobulin G class enteric neuronal antibodies in high titer (1:5000-8000). The staining of central nervous system neuronal nuclei and Western blotting indicated the presence of antineuronal nuclear protein antibodies of the ANNA-1 (anti-Hu) type usually associated with paraneoplastic sensory neuropathy. However, the reaction pattern in enteric neurons was quite different with strong reaction to perikarya and only weak staining of nuclear antigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098023     DOI: 10.1016/s0016-5085(97)70151-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

Review 1.  Fundamentals of neurogastroenterology.

Authors:  J D Wood; D H Alpers; P L Andrews
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Actions of bradykinin on electrical and synaptic behavior of neurones in the myenteric plexus of guinea-pig small intestine.

Authors:  Hong-Zhen Hu; Sumei Liu; Na Gao; Yun Xia; Randa Mostafa; Jun Ren; Dimiter H Zafirov; Jackie D Wood
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 3.  Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction.

Authors:  R De Giorgio; G Sarnelli; R Corinaldesi; V Stanghellini
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

4.  Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study.

Authors:  Sean J Pittock; Vanda A Lennon; Carissa L Dege; Nicholas J Talley; G Richard Locke
Journal:  Dig Dis Sci       Date:  2010-12-23       Impact factor: 3.199

5.  Redo transanal endorectal pull-through: a preliminary study.

Authors:  T A Gobran; A Ezzat; M E Hassan; J O'Neill
Journal:  Pediatr Surg Int       Date:  2006-12-16       Impact factor: 1.827

6.  [The enteric nervous system and interstitial cells of Cajal. Changes in chronic constipation in adults].

Authors:  T Wedel; M Böttner; H J Krammer
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 7.  Chronic intestinal pseudo-obstruction.

Authors:  Alexandra Antonucci; Lucia Fronzoni; Laura Cogliandro; Rosanna-F Cogliandro; Carla Caputo; Roberto De Giorgio; Francesca Pallotti; Giovanni Barbara; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 8.  Abnormal layering of muscularis propria as a cause of chronic intestinal pseudo-obstruction: A case report and literature review.

Authors:  Napat Angkathunyakul; Suporn Treepongkaruna; Sani Molagool; Nichanan Ruangwattanapaisarn
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

9.  Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.

Authors:  S Bruley des Varannes; J Chevalier; S Pimont; J-C Le Neel; M Klotz; K-H Schafer; J-P Galmiche; M Neunlist
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

10.  Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea.

Authors:  Barbara Wildhaber; Felix Niggli; Eva Bergsträsser; Thomas Stallmach; Peter Sacher
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.